Skip to main content
Passa alla visualizzazione normale.

DONATELLA FERRARO

Effects of Eradicating Hepatitis C Virus Infection in Patients With Cirrhosis Differ With Stage of Portal Hypertension

  • Authors: Di Marco, V.; Calvaruso, V.; Ferraro, D.; Bavetta, M.; Cabibbo, G.; Conte, E.; Cammà, C.; Grimaudo, S.; Pipitone, R.; Simone, F.; Peralta, S.; Arini, A.; Craxì, A.
  • Publication year: 2016
  • Type: Articolo in rivista (Articolo in rivista)
  • OA Link: http://hdl.handle.net/10447/191041

Abstract

Clearance of hepatitis C virus (HCV) via antiviral treatment changes the course of liver disease. We evaluated the benefit of sustained virologic response (SVR) in patients with HCV and cirrhosis without (stage 1) and with (stage 2) esophageal varices (EV).